Explore

Trendline Trendline
Corcept Therapeutics Faces Securities Fraud Lawsuit Led by Rosen Law Firm

Corcept Therapeutics Faces Securities Fraud Lawsuit Led by Rosen Law Firm

Corcept Therapeutics Faces Securities Fraud Lawsuit Led by Rosen Law Firm
Trendline Trendline
Corcept Therapeutics Faces Securities Fraud Lawsuit Over Misleading FDA Approval Claims

Corcept Therapeutics Faces Securities Fraud Lawsuit Over Misleading FDA Approval Claims

Corcept Therapeutics Faces Securities Fraud Lawsuit Over Misleading FDA Approval Claims
Trendline Trendline
Rosen Law Firm Urges Corcept Therapeutics Investors to Lead Securities Fraud Lawsuit

Rosen Law Firm Urges Corcept Therapeutics Investors to Lead Securities Fraud Lawsuit

Rosen Law Firm Urges Corcept Therapeutics Investors to Lead Securities Fraud Lawsuit
Trendline Trendline
Cingulate's ADHD Drug Faces FDA Manufacturing Review, No Safety Concerns Reported

Cingulate's ADHD Drug Faces FDA Manufacturing Review, No Safety Concerns Reported

Cingulate's ADHD Drug Faces FDA Manufacturing Review, No Safety Concerns Reported
Trendline Trendline
Insmed Halts Development of Skin Treatment Amid Competitive Advances

Insmed Halts Development of Skin Treatment Amid Competitive Advances

Insmed Halts Development of Skin Treatment Amid Competitive Advances
Trendline Trendline
Rosen Law Firm Urges Corcept Therapeutics Investors to Act Before Class Action Deadline

Rosen Law Firm Urges Corcept Therapeutics Investors to Act Before Class Action Deadline

Rosen Law Firm Urges Corcept Therapeutics Investors to Act Before Class Action Deadline
Trendline Trendline
Rosen Law Firm Files Class Action Against Aldeyra Therapeutics Over Misleading Statements

Rosen Law Firm Files Class Action Against Aldeyra Therapeutics Over Misleading Statements

Rosen Law Firm Files Class Action Against Aldeyra Therapeutics Over Misleading Statements
Trendline Trendline
Rosen Law Firm Files Class Action Against Pinterest for Misleading Investors

Rosen Law Firm Files Class Action Against Pinterest for Misleading Investors

Rosen Law Firm Files Class Action Against Pinterest for Misleading Investors
Trendline Trendline
Rosen Law Firm Urges Apollo Global Management Investors to Join Securities Class Action

Rosen Law Firm Urges Apollo Global Management Investors to Join Securities Class Action

Rosen Law Firm Urges Apollo Global Management Investors to Join Securities Class Action
Trendline Trendline
FDA Decision on Replimune's RP1 Drug Could Signal Regulatory Direction for Biopharma

FDA Decision on Replimune's RP1 Drug Could Signal Regulatory Direction for Biopharma

FDA Decision on Replimune's RP1 Drug Could Signal Regulatory Direction for Biopharma
Trendline Trendline
Rosen Law Firm Urges Super Micro Computer Investors to Act Before Class Action Deadline

Rosen Law Firm Urges Super Micro Computer Investors to Act Before Class Action Deadline

Rosen Law Firm Urges Super Micro Computer Investors to Act Before Class Action Deadline
Trendline Trendline
PayPal Faces Securities Fraud Class Action with April 2026 Deadline for Investors

PayPal Faces Securities Fraud Class Action with April 2026 Deadline for Investors

PayPal Faces Securities Fraud Class Action with April 2026 Deadline for Investors